NCT03389724 2022-11-08
Prevention of Chemotherapy Induced Cardiotoxicity in Children With Bone Tumors and Acute Myeloid Leukemia
Children's Cancer Hospital Egypt 57357
Phase 3 Completed
Clinical Trials
9 trialsNCT01724450 2018-02-05
Ceccy
University of Sao Paulo
Phase 3 Completed
NCT00459771 2014-12-02
Evaluating the Effect of Candesartan vs Placebo in Prevention of Trastuzumab-associated Cardiotoxicity
The Netherlands Cancer Institute
Phase 3 Completed
NCT00854568 2014-08-20
Comparison Study of Doxorubicin Versus Epirubicin-induced Cardiotoxicity in Patients With DLBCL
Fudan University
Phase 3 Completed
NCT00003070 2014-08-05
Enalapril in Treating Heart Damage Patients Who Received Anthracycline Chemotherapy for Childhood Cancer
Children's Oncology Group
Phase 3 Completed
NCT00003937 2014-08-05
Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed Nonmetastatic Osteosarcoma
Children's Oncology Group
Phase 3 Completed
NCT00005578 2014-07-24
Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin's Disease
Children's Oncology Group
Phase 3 Completed
NCT00002827 2013-08-26
Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Disease
Children's Oncology Group
Phase 3 Completed
NCT01230983 2013-06-06
T-Cell #4
Children's Oncology Group
Phase 3 Completed